Histopathological Analysis of Testicular Lesions in Tertiary Care Center

<p>Introduction:Testicular tumors are relatively rare malignancies that primarily affect<br>young men, typically between the ages of 20 and 40 years. Testicular lesions requiring<br>orchidectomy can be both neoplastic and non-neoplastic conditions. Non-neoplastic<br>lesions are more prevalent than neoplastic ones. Incidence rates of testicular tumors<br>show considerable geographical variation, and interestingly, they exhibit aninverse<br>pattern to most cancers, with decreasing incidence as age increases. Surgical removal<br>of the affected testis (orchiectomy) remains the cornerstone of treatment, often<br>followed by chemotherapy or radiation, depending on the stage and histology.<br>Material and Method: This was a retrospective study, in which total 30 testicular<br>cases were retrieved from database between July 2022 to June 2023, in the department<br>of pathology, SMIMER, Surat.<br>Results: There was a total of 30 specimens received in the department of pathology,<br>during the study period. 30%(9 specimen) of the total specimen does not have definite<br>diagnosis(descriptive), 16.6% (5 specimen) was of torsion of testis, 13.3% (4<br>specimen) was of cryptorchidism, 6.6% (2 specimen) was of atrophy of testis, 6.6% (2<br>specimen) was of inflammation of testis, 6.6%(2 specimen) was of granulomatous<br>inflammation of testis, 6.6% (2 specimen) was of ectopic testis, 3.3% (1 specimen) was<br>of classic seminoma, 3.3% (1 specimen) was of spermatolytic tumor, 3.3%(1 specimen)<br>was of Leydig cell tumor, 3.3% (1 specimen) was of Germ cell tumors derived from<br>germ cell neoplasia in situ (GCNIS) - mixed Germ cell tumor- Teratoma- post pubertal<br>type (Immature teratoma) (70%) + Yolk sac tumor (30%).<br>Conclusion: Testicular tumors are uncommon in our population.Non-neoplastic lesions<br>are more prevalent than neoplastic ones. According to new WHO classification 2022<br>5<br>th edition there are new changes. These are the changes. Spermatocytic tumor and<br>seminoma both are germ cell tumors. Spermatocytic tumor is included in Germ cell<br>tumor unrelated to germ cell neoplasia in situ. Seminoma is included in Germ cell<br>tumors derived from germ cell neoplasia in situ (GCNIS).</p>

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-06
DOI
https://doi.org/10.5281/zenodo.14978712
Primary Topic
Testicular diseases and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Histopathological Analysis of Testicular Lesions in Tertiary Care Center

Zenodo (CERN European Organization for Nuclear Research)
Testicular diseases and treatments
article

Histopathological Analysis of Testicular Lesions in Tertiary Care Center

article en

Abstract

<p>Introduction:Testicular tumors are relatively rare malignancies that primarily affect<br>young men, typically between the ages of 20 and 40 years. Testicular lesions requiring<br>orchidectomy can be both neoplastic and non-neoplastic conditions. Non-neoplastic<br>lesions are more prevalent than neoplastic ones. Incidence rates of testicular tumors<br>show considerable geographical variation, and interestingly, they exhibit aninverse<br>pattern to most cancers, with decreasing incidence as age increases. Surgical removal<br>of the affected testis (orchiectomy) remains the cornerstone of treatment, often<br>followed by chemotherapy or radiation, depending on the stage and histology.<br>Material and Method: This was a retrospective study, in which total 30 testicular<br>cases were retrieved from database between July 2022 to June 2023, in the department<br>of pathology, SMIMER, Surat.<br>Results: There was a total of 30 specimens received in the department of pathology,<br>during the study period. 30%(9 specimen) of the total specimen does not have definite<br>diagnosis(descriptive), 16.6% (5 specimen) was of torsion of testis, 13.3% (4<br>specimen) was of cryptorchidism, 6.6% (2 specimen) was of atrophy of testis, 6.6% (2<br>specimen) was of inflammation of testis, 6.6%(2 specimen) was of granulomatous<br>inflammation of testis, 6.6% (2 specimen) was of ectopic testis, 3.3% (1 specimen) was<br>of classic seminoma, 3.3% (1 specimen) was of spermatolytic tumor, 3.3%(1 specimen)<br>was of Leydig cell tumor, 3.3% (1 specimen) was of Germ cell tumors derived from<br>germ cell neoplasia in situ (GCNIS) - mixed Germ cell tumor- Teratoma- post pubertal<br>type (Immature teratoma) (70%) + Yolk sac tumor (30%).<br>Conclusion: Testicular tumors are uncommon in our population.Non-neoplastic lesions<br>are more prevalent than neoplastic ones. According to new WHO classification 2022<br>5<br>th edition there are new changes. These are the changes. Spermatocytic tumor and<br>seminoma both are germ cell tumors. Spermatocytic tumor is included in Germ cell<br>tumor unrelated to germ cell neoplasia in situ. Seminoma is included in Germ cell<br>tumors derived from germ cell neoplasia in situ (GCNIS).</p>

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 36%
Testicular diseases and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Histopathological Analysis of Testicular Lesions in Tertiary Care Center · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS